FAM184A inhibitors are chemical compounds specifically designed to target and inhibit the function of the FAM184A protein. FAM184A is a member of the FAM (family with sequence similarity) proteins, which are known for their role in various biological processes, though many of these proteins remain poorly characterized. The inhibition of FAM184A, therefore, can be seen as a key approach to exploring its biological significance and its participation in cellular pathways. Structurally, FAM184A inhibitors are tailored to interact with specific binding sites on the FAM184A protein, typically through non-covalent interactions such as hydrogen bonding, hydrophobic forces, and van der Waals interactions. These inhibitors may possess diverse chemical backbones that allow them to specifically fit into the active or allosteric sites of FAM184A, thereby modulating its function.
The development of FAM184A inhibitors often involves iterative design, guided by structure-activity relationships (SAR), molecular docking, and other computational techniques to optimize their selectivity and potency. These inhibitors serve as invaluable tools for studying the biological roles of FAM184A in vitro and in vivo, allowing researchers to dissect the protein's interaction networks, post-translational modifications, and its regulation within different cellular compartments. In addition to being useful for exploring the fundamental biology of FAM184A, these inhibitors help in understanding how alterations in FAM184A activity affect various biochemical processes, such as signal transduction pathways, cellular metabolism, and gene expression. Researchers use these inhibitors in laboratory settings to determine the consequences of FAM184A inhibition on cellular function, opening doors for further mechanistic insights into its physiological roles.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor. If FAM184A is related to cell cycle regulation, this can impact its activity. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $207.00 | 8 | |
Dual PI3K/mTOR inhibitor. Useful if FAM184A has connections with the PI3K/Akt/mTOR pathway. | ||||||
PI3K/HDAC Inhibitor | 1339928-25-4 | sc-364584 sc-364584A | 5 mg 10 mg | $340.00 $462.00 | ||
Dual PI3K/HDAC inhibitor. May influence FAM184A if it's linked with PI3K signaling and chromatin remodeling. | ||||||
INK 128 | 1224844-38-5 | sc-364511 sc-364511A | 5 mg 50 mg | $315.00 $1799.00 | ||
mTOR inhibitor. Relevant if FAM184A functions are tied to mTOR-mediated signaling. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
PARP inhibitor. May indirectly influence FAM184A if it's associated with DNA repair pathways. | ||||||
Cobimetinib | 934660-93-2 | sc-507421 | 5 mg | $270.00 | ||
MEK inhibitor, affecting the MAPK/ERK pathway, which can intersect with FAM184A's functions. | ||||||
KPT 330 | 1393477-72-9 | sc-489062 | 5 mg | $170.00 | ||
Exportin-1 inhibitor. May influence FAM184A if it's involved in nuclear export processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
HDAC inhibitor. Relevant if FAM184A has interactions with histone modification processes. | ||||||
Vandetanib | 443913-73-3 | sc-220364 sc-220364A | 5 mg 50 mg | $167.00 $1353.00 | ||
VEGFR inhibitor. If FAM184A has roles in angiogenesis, this can provide insights. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
Multi-kinase inhibitor. Useful to understand FAM184A's roles in various kinase-mediated signaling. |